Open Access
Numéro |
Ann Toxicol Anal
Volume 24, Numéro 1, 2012
|
|
---|---|---|
Page(s) | 23 - 27 | |
DOI | https://doi.org/10.1051/ata/2011136 | |
Publié en ligne | 3 février 2012 |
- Beck F, Guignard R, Richard J, Tovar M, Spilka S. Les niveaux d'usage des drogues en France en 2010. Tendances. 2011; 76: 1–6. [Google Scholar]
- Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacol Rev. 2003; 55(3): 463–508. [CrossRef] [PubMed] [Google Scholar]
- de la Torre R, Farre M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Cami J. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004; 26(2): 137–144. [CrossRef] [PubMed] [Google Scholar]
- Luciana M, Burgund ED, Berman M, Hanson KL. Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. J Psychopharmacol. 2001; 15(4): 219–230. [CrossRef] [PubMed] [Google Scholar]
- Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL. The health effects of ecstasy: a literature review. Drug Alcohol Rev. 2002; 21(1): 53–63. [CrossRef] [PubMed] [Google Scholar]
- Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ. 2001; 165(7): 917–928. [PubMed] [Google Scholar]
- Gouzoulis-Mayfrank E, Daumann J. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol. 2006; 20(2): 188–193. [CrossRef] [PubMed] [Google Scholar]
- Chèze M, Deveaux M, Martin C, Lhermitte M, Pepin G. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake. Forensic Sci Int. 2007; 170(2-3): 100–104. [Google Scholar]
- Chèze M, Duffort G, Deveaux M, Pepin G. Hair analysis by liquid chromatography-tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: report of 128 cases over the period June 2003-May 2004 in metropolitan Paris. Forensic Sci Int. 2005; 153(1): 3–10. [CrossRef] [PubMed] [Google Scholar]
- Document consulté sur le site http://sfta.org/presentation/main/consensus/techniques/consensuscheveux.htm le 20 juillet 2011. [Google Scholar]
- Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO, Gorelick DA, Goodwin RS, Huestis MA. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. J Anal Toxicol. 2009; 33(8): 439–446. [PubMed] [Google Scholar]
- Scholey AB, Owen L, Gates J, Rodgers J, Buchanan T, Ling J, Heffernan T, Swan P, Stough C, Parrott AC. Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory. Neuropsychobiology. 2011; 63(1): 15–21. [CrossRef] [PubMed] [Google Scholar]
- Spatt J, Glawar B, Mamoli B. A pure amnestic syndrome after MDMA (“ecstasy”) ingestion. J Neurol Neurosurg Psychiatry. 1997; 62(4): 418–419. [CrossRef] [Google Scholar]
- Deveaux M, Hoizey G, Chèze M, Muckensturm A, Pélissier-Alicot AL, Pépin G. Findings of MDMA and MDA in hair, blood and urine by LC-ESI-MS/MS: report of 11 drug facilitated crime cases with anterograde amnesia. San Francisco, CA: SOHT-TIAFT 2011. [Google Scholar]
- Goullé J, Anger J. Effet amnésiant des hypnotiques médicamenteux. Revue de la littérature. Cas personnels. Ann Toxicol Anal. 2002; XIV(4): 381–389. [CrossRef] [EDP Sciences] [Google Scholar]
- Kuypers KP, Ramaekers JG. Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology (Berl). 2007; 189(4): 557–563. [CrossRef] [PubMed] [Google Scholar]
- McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology (Berl). 2004; 173(3-4): 434–439. [CrossRef] [PubMed] [Google Scholar]
- Nulsen CE, Fox AM, Hammond GR. Differential effects of ecstasy on short-term and working memory: a meta-analysis. Neuropsychol Rev. 2010; 20(1): 21–32. [CrossRef] [PubMed] [Google Scholar]
- Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de La Torre R. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther. 2002; 300(1): 236–244. [CrossRef] [PubMed] [Google Scholar]
- Upreti VV, Eddington ND, Moon KH, Song BJ, Lee IJ. Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine (“ecstasy”). Toxicol Lett. 2009; 188(2): 167–172. [CrossRef] [PubMed] [Google Scholar]
- Hamida SB, Tracqui A, de Vasconcelos AP, Szwarc E, Lazarus C, Kelche C, Jones BC, Cassel JC. Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA. Int J Neuropsychopharmacol. 2009; 12(6): 749–759. [CrossRef] [PubMed] [Google Scholar]
- Hernandez-Rabaza V, Navarro-Mora G, Velazquez-Sanchez C, Ferragud A, Marin MP, Garcia-Verdugo JM, Renau-Piqueras J, Canales JJ. Neurotoxicity and persistent cognitive deficits induced by combined MDMA and alcohol exposure in adolescent rats. Addict Biol. 2010; 15(4): 413–423. [CrossRef] [PubMed] [Google Scholar]
- Cassel JC, Riegert C, Rutz S, Koenig J, Rothmaier K, Cosquer B, Lazarus C, Birthelmer A, Jeltsch H, Jones BC, Jackisch R. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. Neuropsychopharmacology. 2005; 30(10): 1870–1882. [CrossRef] [PubMed] [Google Scholar]
- Dumont GJ, Wezenberg E, Valkenberg MM, de Jong CA, Buitelaar JK, van Gerven JM, Verkes RJ. Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers. Psychopharmacology (Berl). 2008; 197(3): 465–474. [CrossRef] [PubMed] [Google Scholar]
- Lee H, Roh S, Kim DJ. Alcohol-induced blackout. Int J Environ Res Public Health. 2009; 6(11): 2783–2792. [CrossRef] [PubMed] [Google Scholar]